G6PC1 and Hyperglycemia: These pharmacological results are in line with antisense oligonucleotide studies demonstrating that liver-specific KD of GR diminishes hepatic expression of G6PC and PEPCK and lessens hyperglycemia in obese diabetic ob/ob and db/db mice [35].